TrialPanorama/Dataset huggingface dataset:
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Restore Claims Characterization Study
Brief Summary: The purpose of this study is to characterize the pain coverage capability of the RESTORE spinal cord stimulation (SCS) and assess health outcomes.


Options:
A: Arm Label: Spinal Cord Stimulation; Type: EXPERIMENTAL; Interventions: Device: WaveWriter | Arm Label: Conventional Medical Management; Type: OTHER; Interventions: Other: Conventional Medical Managament | Intervention Type: DEVICE; Name: WaveWriter; Assigned to Arm(s): Spinal Cord Stimulation | Intervention Type: OTHER; Name: Conventional Medical Managament; Assigned to Arm(s): Conventional Medical Management
B: Intervention Type: DEVICE; Name: Spinal Cord Stimulation; Assigned to Arm(s): N/A
C: Arm Label: Group A - active treatment; Type: EXPERIMENTAL; Interventions: Device: Spinal cord stimulation by implanted device. | Arm Label: Group B - conservative management; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: DEVICE; Name: Spinal cord stimulation by implanted device.; Assigned to Arm(s): Group A - active treatment
D: Arm Label: Spinal Cord Stimulation; Type: EXPERIMENTAL; Interventions: Procedure: Spinal Cord Stimulation | Arm Label: Treatment as usual; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: PROCEDURE; Name: Spinal Cord Stimulation; Assigned to Arm(s): Spinal Cord Stimulation

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Restore Claims Characterization Study
Brief Summary: The purpose of this study is to characterize the pain coverage capability of the RESTORE spinal cord stimulation (SCS) and assess health outcomes.


Options:
A: Arm Label: Spinal Cord Stimulation (SCS); Type: ACTIVE_COMPARATOR; Interventions: Device: Spinal Cord Stimulation (SCS), Other: Physiotherapy | Arm Label: Physiotherapy; Type: ACTIVE_COMPARATOR; Interventions: Device: Spinal Cord Stimulation (SCS), Other: Physiotherapy | Intervention Type: DEVICE; Name: Spinal Cord Stimulation (SCS); Assigned to Arm(s): Physiotherapy, Spinal Cord Stimulation (SCS) | Intervention Type: OTHER; Name: Physiotherapy; Assigned to Arm(s): Physiotherapy, Spinal Cord Stimulation (SCS)
B: Arm Label: Burst-SCS/sham SCS; Type: OTHER; Interventions: Device: Burst-SCS, Device: Sham SCS | Arm Label: Sham SCS/Burst-SCS; Type: OTHER; Interventions: Device: Burst-SCS, Device: Sham SCS | Intervention Type: DEVICE; Name: Burst-SCS; Assigned to Arm(s): Burst-SCS/sham SCS, Sham SCS/Burst-SCS | Intervention Type: DEVICE; Name: Sham SCS; Assigned to Arm(s): Burst-SCS/sham SCS, Sham SCS/Burst-SCS
C: Arm Label: Burst spinal cord stimulation (SCS); Type: EXPERIMENTAL; Interventions: Procedure: Burst Spinal Cord Stimulation, Procedure: Sham spinal cord stimulation | Arm Label: sham spinal cord stimulation (SCS); Type: SHAM_COMPARATOR; Interventions: Procedure: Burst Spinal Cord Stimulation, Procedure: Sham spinal cord stimulation | Intervention Type: PROCEDURE; Name: Burst Spinal Cord Stimulation; Assigned to Arm(s): Burst spinal cord stimulation (SCS), sham spinal cord stimulation (SCS) | Intervention Type: PROCEDURE; Name: Sham spinal cord stimulation; Assigned to Arm(s): Burst spinal cord stimulation (SCS), sham spinal cord stimulation (SCS)
D: Intervention Type: DEVICE; Name: Spinal Cord Stimulation; Assigned to Arm(s): N/A

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Restore Claims Characterization Study
Brief Summary: The purpose of this study is to characterize the pain coverage capability of the RESTORE spinal cord stimulation (SCS) and assess health outcomes.


Options:
A: Intervention Type: DEVICE; Name: Spinal Cord Stimulation; Assigned to Arm(s): N/A
B: Arm Label: Burst spinal cord stimulation (SCS); Type: EXPERIMENTAL; Interventions: Procedure: Burst Spinal Cord Stimulation, Procedure: Sham spinal cord stimulation | Arm Label: sham spinal cord stimulation (SCS); Type: SHAM_COMPARATOR; Interventions: Procedure: Burst Spinal Cord Stimulation, Procedure: Sham spinal cord stimulation | Intervention Type: PROCEDURE; Name: Burst Spinal Cord Stimulation; Assigned to Arm(s): Burst spinal cord stimulation (SCS), sham spinal cord stimulation (SCS) | Intervention Type: PROCEDURE; Name: Sham spinal cord stimulation; Assigned to Arm(s): Burst spinal cord stimulation (SCS), sham spinal cord stimulation (SCS)
C: Arm Label: Spinal Cord Stimulation; Type: EXPERIMENTAL; Interventions: Device: WaveWriter | Arm Label: Conventional Medical Management; Type: OTHER; Interventions: Other: Conventional Medical Managament | Intervention Type: DEVICE; Name: WaveWriter; Assigned to Arm(s): Spinal Cord Stimulation | Intervention Type: OTHER; Name: Conventional Medical Managament; Assigned to Arm(s): Conventional Medical Management
D: Arm Label: SCS starting with supra-perception; Type: ACTIVE_COMPARATOR; Interventions: Device: Precision or Precision Spectra Spinal Cord Stimulator System | Arm Label: SCS starting with sub-perception amplitude; Type: EXPERIMENTAL; Interventions: Device: Precision or Precision Spectra Spinal Cord Stimulator System | Intervention Type: DEVICE; Name: Precision or Precision Spectra Spinal Cord Stimulator System; Assigned to Arm(s): SCS starting with sub-perception amplitude, SCS starting with supra-perception

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Development and Evaluation of a SlimFast Internet Behavioral Weight Loss Program
Brief Summary: The Internet has been used effectively in behavioral weight loss programs. Most of these programs have involved a therapist who provides email counseling. The purpose of this study was to determine whether a computer-assisted weight loss program could be developed (that would use pre-programmed computer generated messages rather than human generated messages) and whether this program would be as effective as the therapist-assisted weight loss program.


Options:
A: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Behavioral: group sessions, Drug: sibutramine, orlistat, diethylpropion, Behavioral: Low Calorie Diet, Health One, Other: Intensive Medical Combination Therapy for Obesity | Arm Label: 2; Type: ACTIVE_COMPARATOR; Interventions: Other: Control Condition | Intervention Type: BEHAVIORAL; Name: group sessions; Assigned to Arm(s): 1 | Intervention Type: DRUG; Name: sibutramine, orlistat, diethylpropion; Assigned to Arm(s): 1 | Intervention Type: BEHAVIORAL; Name: Low Calorie Diet, Health One; Assigned to Arm(s): 1 | Intervention Type: OTHER; Name: Intensive Medical Combination Therapy for Obesity; Assigned to Arm(s): 1 | Intervention Type: OTHER; Name: Control Condition; Assigned to Arm(s): 2
B: Intervention Type: BEHAVIORAL; Name: Internet weight loss with SlimFast and human counseling; Assigned to Arm(s): N/A | Intervention Type: BEHAVIORAL; Name: Internet weight loss with SlimFast and computer counseling; Assigned to Arm(s): N/A | Intervention Type: BEHAVIORAL; Name: Internet weight loss program with SlimFast; Assigned to Arm(s): N/A
C: Intervention Type: BEHAVIORAL; Name: Behavior change on physical activity and diet; Assigned to Arm(s): N/A
D: Arm Label: Lifestyle intervention; Type: EXPERIMENTAL; Interventions: Behavioral: Lifestyle Intervention | Arm Label: control; Type: EXPERIMENTAL; Interventions: Other: control group | Intervention Type: BEHAVIORAL; Name: Lifestyle Intervention; Assigned to Arm(s): Lifestyle intervention | Intervention Type: OTHER; Name: control group; Assigned to Arm(s): control

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Interactive Technologies to Increase Exercise Behavior
Brief Summary: The purpose of this study is to examine if an individually tailored Internet intervention is more efficacious than an individually tailored print-based intervention and standard Internet intervention for physical activity adoption and maintenance among sedentary adults.


Options:
A: Intervention Type: BEHAVIORAL; Name: Physical activity (PA) and immigrants; Assigned to Arm(s): N/A
B: Arm Label: PA intervention and Maintenance plus; Type: EXPERIMENTAL; Interventions: Behavioral: Mobile phone based physical activity intervention with maintenance plus | Arm Label: PA intervention and Maintenance regular; Type: EXPERIMENTAL; Interventions: Behavioral: Mobile phone based physical activity intervention with maintenance regular | Arm Label: Pedometer; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Control (pedometer only) | Intervention Type: BEHAVIORAL; Name: Mobile phone based physical activity intervention with maintenance plus; Assigned to Arm(s): PA intervention and Maintenance plus | Intervention Type: BEHAVIORAL; Name: Mobile phone based physical activity intervention with maintenance regular; Assigned to Arm(s): PA intervention and Maintenance regular | Intervention Type: BEHAVIORAL; Name: Control (pedometer only); Assigned to Arm(s): Pedometer
C: Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Mini Booster; Type: EXPERIMENTAL; Interventions: Behavioral: Mini Booster | Arm Label: Full Booster; Type: EXPERIMENTAL; Interventions: Behavioral: Full Booster | Intervention Type: BEHAVIORAL; Name: Mini Booster; Assigned to Arm(s): Mini Booster | Intervention Type: BEHAVIORAL; Name: Full Booster; Assigned to Arm(s): Full Booster
D: Intervention Type: BEHAVIORAL; Name: Internet and print-based interventions; Assigned to Arm(s): N/A

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Interactive Technologies to Increase Exercise Behavior
Brief Summary: The purpose of this study is to examine if an individually tailored Internet intervention is more efficacious than an individually tailored print-based intervention and standard Internet intervention for physical activity adoption and maintenance among sedentary adults.


Options:
A: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Behavioral: Intervention | Arm Label: 2; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Control | Intervention Type: BEHAVIORAL; Name: Intervention; Assigned to Arm(s): 1 | Intervention Type: BEHAVIORAL; Name: Control; Assigned to Arm(s): 2
B: Arm Label: Intervention Group; Type: EXPERIMENTAL; Interventions: Behavioral: Phone counseling with written materials | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Phone counseling with written materials; Assigned to Arm(s): Intervention Group
C: Intervention Type: BEHAVIORAL; Name: Internet and print-based interventions; Assigned to Arm(s): N/A
D: Arm Label: 1- physical activity tailored; Type: EXPERIMENTAL; Interventions: Behavioral: physical activity tailored | Arm Label: 2 - physical activity standard; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: physical activity standard | Intervention Type: BEHAVIORAL; Name: physical activity tailored; Assigned to Arm(s): 1- physical activity tailored | Intervention Type: BEHAVIORAL; Name: physical activity standard; Assigned to Arm(s): 2 - physical activity standard

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Interactive Technologies to Increase Exercise Behavior
Brief Summary: The purpose of this study is to examine if an individually tailored Internet intervention is more efficacious than an individually tailored print-based intervention and standard Internet intervention for physical activity adoption and maintenance among sedentary adults.


Options:
A: Intervention Type: BEHAVIORAL; Name: Internet and print-based interventions; Assigned to Arm(s): N/A
B: Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Mini Booster; Type: EXPERIMENTAL; Interventions: Behavioral: Mini Booster | Arm Label: Full Booster; Type: EXPERIMENTAL; Interventions: Behavioral: Full Booster | Intervention Type: BEHAVIORAL; Name: Mini Booster; Assigned to Arm(s): Mini Booster | Intervention Type: BEHAVIORAL; Name: Full Booster; Assigned to Arm(s): Full Booster
C: Intervention Type: BEHAVIORAL; Name: Physical activity (PA) and immigrants; Assigned to Arm(s): N/A
D: Arm Label: Tailored Physical Activity Intervention Group; Type: EXPERIMENTAL; Interventions: Behavioral: Tailored Physical Activity Intervention | Arm Label: No Tailored Physical Activity Intervention Group; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Tailored Physical Activity Intervention; Assigned to Arm(s): Tailored Physical Activity Intervention Group

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Double-blind, Parallel Group, Placebo-controlled Trial of the Efficacy and Tolerability of Memantine (20 mg) in Frontotemporal Dementia (FTD) Patients
Brief Summary: The purpose of this trial is to assess the efficacy and tolerability of memantine (anti-excitotoxic, neuroprotective treatment currently used in Alzheimer's disease \[AD\]) in frontotemporal dementia patients after a one-year treatment.


Options:
A: Arm Label: Memantine; Type: EXPERIMENTAL; Interventions: Drug: Memantine | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: Memantine; Assigned to Arm(s): Memantine | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo
B: Intervention Type: DRUG; Name: memantine; Assigned to Arm(s): N/A
C: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Drug: memantine | Arm Label: 2; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo pill | Intervention Type: DRUG; Name: memantine; Assigned to Arm(s): 1 | Intervention Type: DRUG; Name: Placebo pill; Assigned to Arm(s): 2
D: Intervention Type: DRUG; Name: Memantine; Assigned to Arm(s): N/A

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Etude Multicentrique Ouverte Randomisée de Phase III Comparant l'Association de VELCADE®-Dexaméthasone à la Chimiothérapie de Type VAD Pour le Traitement Des Patients Porteurs de Myélome Multiple de Novo Jusqu'à l'âge de 65 Ans
Brief Summary: This is an open-label, multi-centre, randomised Phase III study, looking at a series of 480 patients up to the age of 65 with newly diagnosed multiple myeloma (MM) not previously treated. They will receive VAD or Velcade®/dexamethasone combination as induction treatment plus/minus (±) dexamethasone/cyclophosphamide/etoposide/cisplatin (DCEP) followed by autograft as first-line therapy, as the investigators try to compare the complete remission (CR) rate (with negative or positive immunofixation) at the end of their induction treatment.


Options:
A: Intervention Type: DRUG; Name: Velcade; Assigned to Arm(s): N/A
B: Arm Label: VTD; Type: EXPERIMENTAL; Interventions: Drug: Velcade, Drug: Thalidomide, Drug: Dexamethasone, Procedure: Peripheral Blood Stem Cell (PBSC) collection, Procedure: First Autologous Transplantation, Procedure: Second Autologous Transplantation | Arm Label: TD; Type: ACTIVE_COMPARATOR; Interventions: Drug: Thalidomide, Drug: Dexamethasone, Procedure: Peripheral Blood Stem Cell (PBSC) collection, Procedure: First Autologous Transplantation, Procedure: Second Autologous Transplantation | Intervention Type: DRUG; Name: Velcade; Assigned to Arm(s): VTD | Intervention Type: DRUG; Name: Thalidomide; Assigned to Arm(s): TD, VTD | Intervention Type: DRUG; Name: Dexamethasone; Assigned to Arm(s): TD, VTD | Intervention Type: PROCEDURE; Name: Peripheral Blood Stem Cell (PBSC) collection; Assigned to Arm(s): TD, VTD | Intervention Type: PROCEDURE; Name: First Autologous Transplantation; Assigned to Arm(s): TD, VTD | Intervention Type: PROCEDURE; Name: Second Autologous Transplantation; Assigned to Arm(s): TD, VTD
C: Intervention Type: DRUG; Name: Alternating chemotherapy; Assigned to Arm(s): N/A | Intervention Type: PROCEDURE; Name: Autologous Transplantation; Assigned to Arm(s): N/A | Intervention Type: DRUG; Name: Maintenance; Assigned to Arm(s): N/A | Intervention Type: PROCEDURE; Name: Second transplantation; Assigned to Arm(s): N/A | Intervention Type: PROCEDURE; Name: ALOGENIC MINI TRASPLANTATION; Assigned to Arm(s): N/A
D: Intervention Type: PROCEDURE; Name: autologous PBSC transplant; Assigned to Arm(s): N/A

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Etude Multicentrique Ouverte Randomisée de Phase III Comparant l'Association de VELCADE®-Dexaméthasone à la Chimiothérapie de Type VAD Pour le Traitement Des Patients Porteurs de Myélome Multiple de Novo Jusqu'à l'âge de 65 Ans
Brief Summary: This is an open-label, multi-centre, randomised Phase III study, looking at a series of 480 patients up to the age of 65 with newly diagnosed multiple myeloma (MM) not previously treated. They will receive VAD or Velcade®/dexamethasone combination as induction treatment plus/minus (±) dexamethasone/cyclophosphamide/etoposide/cisplatin (DCEP) followed by autograft as first-line therapy, as the investigators try to compare the complete remission (CR) rate (with negative or positive immunofixation) at the end of their induction treatment.


Options:
A: Arm Label: No treatment; Type: ACTIVE_COMPARATOR; Interventions: Drug: bortezomib | Arm Label: Bortezomib consolidation; Type: EXPERIMENTAL; Interventions: Drug: bortezomib | Intervention Type: DRUG; Name: bortezomib; Assigned to Arm(s): Bortezomib consolidation, No treatment
B: Intervention Type: DRUG; Name: Velcade; Assigned to Arm(s): N/A
C: Arm Label: carfilzomib (A0); Type: EXPERIMENTAL; Interventions: Drug: carfilzomib | Arm Label: carfilzomib (A1); Type: EXPERIMENTAL; Interventions: Drug: carfilzomib | Intervention Type: DRUG; Name: carfilzomib; Assigned to Arm(s): carfilzomib (A0) | Intervention Type: DRUG; Name: carfilzomib; Assigned to Arm(s): carfilzomib (A1)
D: Arm Label: Arm A: VMPT; Type: EXPERIMENTAL; Interventions: Drug: Bortezomib, Melphalan, Prednisone, Thalidomide | Arm Label: VMP; Type: ACTIVE_COMPARATOR; Interventions: Drug: Bortezomib, Melphalan, Prednisone | Intervention Type: DRUG; Name: Bortezomib, Melphalan, Prednisone, Thalidomide; Assigned to Arm(s): Arm A: VMPT | Intervention Type: DRUG; Name: Bortezomib, Melphalan, Prednisone; Assigned to Arm(s): VMP

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Intracoronary Injection of Autologous Bone Marrow Mononuclear Cells for Severe Myocardial Infarction
Brief Summary: Emerging evidence suggests that stem cells and progenitor cells derived from bone marrow can be used to improve cardiac function in patients after acute myocardial infarction. In this randomised trial, we aim to assess whether intracoronary transfer of autologous bone-marrow cells could improve myocardial viability at 3 and 12 months' follow-up.


Options:
A: Arm Label: Treated Group; Type: EXPERIMENTAL; Interventions: Procedure: Autologous Bone Marrow Mononuclear Cells (ABMMC) Transplantation | Arm Label: Control Group; Type: PLACEBO_COMPARATOR; Interventions: Procedure: Autologous Bone Marrow Mononuclear Cells (ABMMC) Transplantation | Intervention Type: PROCEDURE; Name: Autologous Bone Marrow Mononuclear Cells (ABMMC) Transplantation; Assigned to Arm(s): Control Group, Treated Group
B: Arm Label: The treatment group; Type: EXPERIMENTAL; Interventions: Procedure: Intracoronary injection of autologous bone marrow mononuclear cells | Arm Label: the control group; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: PROCEDURE; Name: Intracoronary injection of autologous bone marrow mononuclear cells; Assigned to Arm(s): The treatment group
C: Arm Label: Cardiac Stem Cell Treatment - Group 1; Type: EXPERIMENTAL; Interventions: Biological: Autologous stem cell infusion | Arm Label: Cardiac Stem Cell Treatment -Group 2; Type: EXPERIMENTAL; Interventions: Biological: Autologous stem cell infusion | Arm Label: Observation (Control Group); Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BIOLOGICAL; Name: Autologous stem cell infusion; Assigned to Arm(s): Cardiac Stem Cell Treatment - Group 1 | Intervention Type: BIOLOGICAL; Name: Autologous stem cell infusion; Assigned to Arm(s): Cardiac Stem Cell Treatment -Group 2
D: Intervention Type: DRUG; Name: G-CSF with/without darbepoetin, peripheral blood stem cell infusion; Assigned to Arm(s): N/A

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Treatment of Obesity in Underserved Rural Settings (TOURS)
Brief Summary: To test the effectiveness of interventions designed to promote long-term weight management of obese women in medically underserved rural counties.


Options:
A: Arm Label: Personal contact (PC); Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Personal contact (PC) | Arm Label: Interactive technology (IT); Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Interactive technology (IT) | Intervention Type: BEHAVIORAL; Name: Personal contact (PC); Assigned to Arm(s): Personal contact (PC) | Intervention Type: BEHAVIORAL; Name: Interactive technology (IT); Assigned to Arm(s): Interactive technology (IT)
B: Arm Label: Face-to-face counseling; Type: EXPERIMENTAL; Interventions: Behavioral: Face-to-face counseling | Arm Label: Telephone Counseling; Type: EXPERIMENTAL; Interventions: Behavioral: Telephone counseling | Arm Label: Mail contact; Type: ACTIVE_COMPARATOR; Interventions: Other: Mail contact | Intervention Type: BEHAVIORAL; Name: Face-to-face counseling; Assigned to Arm(s): Face-to-face counseling | Intervention Type: BEHAVIORAL; Name: Telephone counseling; Assigned to Arm(s): Telephone Counseling | Intervention Type: OTHER; Name: Mail contact; Assigned to Arm(s): Mail contact
C: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Behavioral: group sessions, Drug: sibutramine, orlistat, diethylpropion, Behavioral: Low Calorie Diet, Health One, Other: Intensive Medical Combination Therapy for Obesity | Arm Label: 2; Type: ACTIVE_COMPARATOR; Interventions: Other: Control Condition | Intervention Type: BEHAVIORAL; Name: group sessions; Assigned to Arm(s): 1 | Intervention Type: DRUG; Name: sibutramine, orlistat, diethylpropion; Assigned to Arm(s): 1 | Intervention Type: BEHAVIORAL; Name: Low Calorie Diet, Health One; Assigned to Arm(s): 1 | Intervention Type: OTHER; Name: Intensive Medical Combination Therapy for Obesity; Assigned to Arm(s): 1 | Intervention Type: OTHER; Name: Control Condition; Assigned to Arm(s): 2
D: Intervention Type: BEHAVIORAL; Name: Behavior change on physical activity and diet; Assigned to Arm(s): N/A

Answer: B